跳至主要内容
临床试验/IRCT20221109056455N1
IRCT20221109056455N1招募中3 期

A prospective randomized controlled study comparing 0.75% hyperbaric ropivacaine with 0.5% hyperbaric bupivacaine in spinal anesthesia for elective caesarean delivery

Tata Main Hospital, Jamshedpur0 个研究点目标入组 98 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • ASA physical status 1 and 2
  • Pregnant adults for elective caesarean section

排除标准

  • Allergy to Ropivacaine or Bupivacaine
  • Infection at the site for spinal anaesthesia
  • Patient with evidence of foetal distress
  • Short stature (150 cm)
  • Tall stature (>180 cm)
  • Obesity(BMI>30)
  • Patient with an obstetrical complication (multiple gestations, bleeding, gestational hypertensive diseases)
  • Psychiatric or seizure disorder
  • Bleeding disorder
  • Cardiac disease

研究者

发起方
Tata Main Hospital, Jamshedpur

相似试验